Ipsen acquires CMTA for $25/sh in cash plus $6 CVR—the $25 price is a 67% premium to Friday’s close: https://finance.yahoo.com/news/ipsen-acquire-clementia-pharmaceuticals-significantly-060000358.html The nominal deal value is $1.31B.